OBJECTIVES The aim of this study was to determine the long-term outcomes (all-cause mortality and sudden cardiac death [SCD]) after medical therapy, alcohol septal ablation (ASA), and myectomy in patients with hypertrophic cardiomyopathy (HCM).
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. o r g / 1 0 . 1 0 1 6 / j . j c h f . 2 0 1 4 . 0 6 . 0 1 2 to define the best strategy (5) (6) (7) (8) . Surgical approaches have been used for more than 5 decades, and at experienced centers, relief of obstruction can be achieved with minimal perioperative morbidity and mortality (9) (10) (11) . However, myectomy is open-heart surgery with relatively long rehabilitation, so in 1995, alcohol septal ablation (ASA), a percutaneous alternative, was developed (12) . This strategy was quickly adopted all over the world, and patients who underwent ASA quickly outnumbered those who underwent myectomy (5) (6) (7) (8) 12, 13) . In some European countries, ASA has fully replaced myectomy (7).
Concerns about ASA remain, however, especially about the arrhythmogenic effect of the ablation scar in patients already at increased risk for lifethreatening arrhythmias (14) (15) (16) (17) .
Although a randomized controlled trial does not seem feasible (18) , and recent meta-analyses (19, 20) evaluated only short-term SCD rate and survival, there is no consensus on the long-term outcomes of ASA (17, (21) (22) (23) (24) . The aim of the present study was therefore to determine the long-term effects of medical treatment, ASA, and myectomy on all-cause mortality and SCD.
METHODS
STUDY DESIGN AND POPULATION. An international multicenter, observational cohort design was used.
The study conformed to the principles of the Declaration of Helsinki. All patients gave informed consent for the intervention, and local institutional review board approval was obtained. Association SCD = sudden cardiac death
Vriesendorp et al. Vriesendorp et al. Table 2 ).
MORTALITY. In 1,047 patients, mean follow-up duration was 7.5 AE 5.3 years (maximum 22.8 years).
There were 156 deaths in the entire cohort ( Table 3) Other characteristics of SCD are described in Table 3 . (2) . ASA was performed in carefully selected patients who were older and had more comorbidities (61% of the deaths were due to noncardiac causes), but despite this, the observed mortality after ASA was not significantly higher than in the other groups. The Values are n (%) or mean AE SD. *In 53 patients (16.5%), the dose of alcohol could not be retrieved. †p < 0.01. ‡p < 0.001.
NA ¼ not applicable; other abbreviations as in Table 1 .
Vriesendorp et al. Studies of short-term follow-up after ASA have described frequent episodes of sustained ventricular tachycardia and ventricular fibrillation (14-17). Our findings confirm this and show that although arrhythmic events were more frequent after ASA (3.1%) than after myectomy (0.4%) (p < 0.001), this had no effect on procedure-related mortality (1.6% vs.
1.2%, p ¼ 0.70). The aim of this study was to assess the long-term effects of the different treatment modalities, especially because the long-term effect of ASA on SCD is unclear.
Two meta-analyses showed that the risk for SCD was not higher in ASA patients than in patients who underwent myectomy. These studies did not focus on long-term outcomes: the mean follow-up period across the cohorts in a study by Agarwal et al. (19) was <3 years, and in a study by Leonardi In older patients or patients with comorbidities and Values are mean AE SD or n (%). *p < 0.05. †p < 0.001 compared with controls. ‡p < 0.01.
CA ¼ cardiac arrest; ICD ¼ implantable cardioverter-defibrillator; other abbreviations as in Table 1 .
Vriesendorp et al.
Long-Term Outcomes in Obstructive HCM D E C E M B E R 2 0 1 4 : 6 3 0 -6 drug-refractory symptoms, and appropriate septal anatomy, the expected survival after ASA is excellent, and in these patients, ASA is a valuable therapy.
Open-heart surgery can be avoided, and rehabilitation is much faster. We recommend that a multidisciplinary heart team (consisting of at least a CI ¼ confidence interval; HR ¼ hazard ratio; other abbreviations as in Table 1 . 
